Your Article Summary
Reversal of refractory septic shock with drotrecogin alpha (activated)
Intensive Care Medicine, 07/01/09
Vieillard-Baron A et al. - The objective of this study was to investigate whether early administration of drotrecogin alpha (activated) (DrotAA) to this selected subgroup of septic patients at extremely high risk of death would significantly improve prognosis. DrotAA therapy was associated with unexpectedly high 28-day survival in patients with "refractory" septic shock.
Related Articles
Standardized order sets for the treatment of severe sepsis and septic shock
Expert Review of Anti-infective Therapy, 11/12/09
Relevance Score: 69%
An explorative study on quality of life and psychological and cognitive function in pediatric survivors of septic shock
Pediatric Critical Care, 11/10/09
Relevance Score: 69%
Corticosteroids for severe sepsis and septic shock
Intensivmedizin und Notfallmedizin, 11/06/09
Relevance Score: 69%
Is pituitary failure the real therapeutic target in septic shock
Medical Hypotheses, 11/04/09
Relevance Score: 69%
Beta-2-Adrenergic Receptor Gene Polymorphism is Associated with Mortality in Septic Shock
American Journal of Respiratory and Critical Care Medicine, 10/27/09
Relevance Score: 68%
Today in Critical Care...keeping you current
Receive free subspecialty "5-minute updates" via email
Implementation of Practice Guidelines for Antifungal Therapy in a Surgical Intensive Care Unit and Its Impact on Use and Costs
Chemotherapy, 12/10/09
Effects of glucose level on early and long-term mortality after intracerebral haemorrhage: the Acute Brain Bleeding Analysis Study
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 12/10/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Blood Pressure, but Not Cerebrospinal Fluid Fentanyl Concentration, Predicts Duration of Labor Analgesia from Spinal Fentanyl
Anesthesiology, 12/10/09
Perioperative Intravenous Amiodarone Does Not Reduce the Burden of Atrial Fibrillation in Patients Undergoing Cardiac Valvular Surgery
Anesthesiology, 12/10/09

See Latest Articles